Sat, May 25, 2013, 6:51 AM EDT - U.S. Markets closed
TTNP was granted priority review for its 6 month implant to treat drug addiction.
Millions are hooked on pain meds and illicit drugs.
TTNP is also advancing its ProNeura technology for Parkinson's and chronic pain.
A $50 million milestone will be earned upon approval on the April 30 PDUFA date.
The royalties are tiered double digit.